查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439250

结构性心臟病设备 - 全球市场回顾、竞争格局、市场预测（2030 年）

Structural Heart Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计2023年全球结构性心臟病器材市场规模为98.1亿美元，2030年将达186.7亿美元，预计2024-2030年期间复合年增长率为11.33%。对结构性心臟病设备的需求主要是由于结构性心臟病患病率的迅速上升、微创干预措施的日益普及、产品开发中研发活动的增加以及新的和先进产品的批准而推动的。各种报销和保险计划中的结构性心臟病设备。

心臟结构器材市场动态

根据2020 年发表在《Lancet》的《 "Global, regional, and national burden of congenital heart disease, 1990-2017：a systematic analysis for the Global Burden of Disease Study 2017》，2017年全球先天性心臟病导致261,247人死亡，其中180,624人是婴儿。儘管由于社会人口指标的增加，与先心病相关的死亡率多年来一直在下降，但先天性疾病的盛行率多年来却在增加，2017年有11,998,283人患有先天性疾病。

根据British Heart Foundation的一份情况说明书，到2022年，英国出生的婴儿中约有五分之一将被诊断出患有心臟异常，这意味着英国平均每天约有13名婴儿被诊断出患有心臟异常。这会导致在以后的生活中做出更多的诊断。据估计，1-2% 的英国人口可能受到冠心病的影响。

Grave 等人于 2020 年在《Journal of the American Heart Association》上发表了 "Epidemiological Features of Aortic Stenosis in a French Nationwide Study: 10-Year Trends and New Challenges" ，主动脉瓣狭窄 (AS) 是欧洲最常见的心臟瓣膜疾病，也是美国第二大常见疾病。主动脉瓣狭窄的盛行率随着年龄的增长而呈指数级增长，据估计，在美国65 岁以下人口中，主动脉瓣狭窄的盛行率为0.2%，在75 岁以上人口中，这一比例为2.8%。

此外，经导管修復和置换等微创手术在结构性心臟病治疗中的日益普及，也为结构性心臟病器械市场的成长带来了重要前景。

然而，产品召回的数量和严格的产品审批监管标准可能会限制预测期内结构性心臟病设备市场的成长。

结构性心臟病设备市场细分分析

在结构性心臟病设备市场的产品领域，与替代设备相比，恢復设备类别预计将占据更大的市场份额。这是因为外科医生更倾向于将修復而不是替换作为首选。这是因为在心臟结构缺陷的治疗中，修復手术往往可以保留心肌的强度和功能，减少术后感染（如心内膜炎）的机会，并且因为置换手术有多种优点。修復程序，包括与设备相比更好的预后以及相对较少的对血液稀释剂的依赖。

在修復手术类别中，瓣膜成形术设备由于其在瓣膜修復手术，尤其是二尖瓣修復手术中的重要性，预计将获得显着的市场份额。瓣膜成形术环被认为是必不可少的，因为它们有助于恢復瓣膜的自然瓣环形状和尺寸，防止未来瓣环扩张，并为瓣环提供功能支撑。此外，这些设备可以灵活地应用于心臟直视手术或微创手术。

该报告提供了全球结构性心臟病设备市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第1章 结构性心臟病设备市场报告简介

第2章 结构性心臟病设备市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估
  • 财务基准

第3章 法规与专利分析

  • 美国
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
  • 日本

第4章 结构性心臟病器材市场的主要驱动因素分析

  • 结构性心臟病设备市场的驱动因素
    • 结构性心臟病盛行率上升
    • 微创手术需求不断成长
    • 技术进步促进新产品开发
    • 将结构性心臟病装置纳入各种报销和保险计划
  • 结构性心臟病器材市场的限制与挑战
    • 频繁的产品故障和召回
    • 严格的产品审批流程
  • 结构性心臟病设备市场的机遇
    • 推出针对新兴市场的产品
    • 提高产品安全性

第5章 结构性心臟病器材市场的波特五力分析

第6章 COVID-19对结构性心臟病器材市场的影响分析

第7章 结构性心臟病器材市场布局

  • 按产品类型
    • 修復手术装置
    • 更换装置
  • 按用途
    • 房间隔缺损
    • 主动脉瓣狭窄
    • 卵圆孔未闭
    • 室间隔缺损
    • 二尖瓣关闭不全
    • 其他
  • 按最终用户
    • 医院
    • 门诊手术中心
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 结构性心臟病器材市场：全球公司份额分析－3至5家主要公司

第9章 结构性心臟病设备市场公司与产品概况

  • Medtronic
  • Boston Scientific Corporation
  • Braile Biomedica
  • Edwards Life Sciences Corporation
  • Valcare Medical
  • W. L. Gore & Associates Inc
  • Abbott
  • XELTIS BV
  • JenaValve Technology, Inc
  • Lepu Medical Technology (Beijing) Co. Ltd
  • Livanova plc
  • Comed BV
  • TORAY INDUSTRIES INC
  • Occlutech International AB
  • Microport Scientific Corporation

第10章 项目方法

  • 二次资料
  • 一次资料
  • 数据三角测量
  • 主要专家意见

第11章 KOL观点

第12章 DelveInsight服务内容

第13章 免责声明

第14章 关于 DelveInsight

Product Code: DIMDCL0037

Structural Heart Devices Market By Product Type (Repair Devices [Occluders, Annuloplasty Devices, Valvuloplasty Devices, Others] And Replacement Devices [Mechanical Heart Valves And Tissue Heart Valves]), By Application (Atrial Spetal Defect, Aortic Valve Stenosis, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Regurgitation, And Others) And By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of structural heart diseases and the development of new products.

Global Structural Heart Devices Market was valued at USD 9.81 billion in 2023, growing at a CAGR of 11.33% during the forecast period from 2024 to 2030 to reach USD 18.67 billion by 2030. The demand for structural heart devices is primarily being boosted by the rapid growth in the prevalence of structural heart diseases, growing popularity of minimally invasive interventions, increase in the research and development activities in product development, the approval of new and advanced products, and the inclusion of structural heart devices in various reimbursement & insurance programs.

Structural Heart Devices Market Dynamics:

As per the Global Burden of Diseases Study published in the Lancet journal in 2020, titled "Global, regional, and national burden of congenital heart disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017", congenital heart disease caused 261,247 deaths across the globe in 2017, of which 180,624 were infants. Even though the mortality rates associated with CHD have decreased over the years due to increasing socio-demographic index, the prevalence of congenital diseases have witnessed an increase over the years with 11,998,283 people living with it in 2017.

According to the factsheet by the British Heart Foundation, 2022, about one in 50 births are diagnosed with heart defects in the UK, which averages to about 13 babies each day in the UK with more diagnoses later in life. Estimates suggest that in total as many as 1-2 per cent of the population in the country may be affected with CHD.

As per the study published in the Journal of the American Heart Association by Grave et al in 2020 titled "Epidemiological Features of Aortic Stenosis in a French Nationwide Study: 10-Year Trends and New Challenges", aortic stenosis (AS) is the most common form of valvular heart disease in Europe, and the second most common indication in the United States. The prevalence of aortic stenosis is estimated to increase exponentially with age and has been estimated at 0.2% of the US population before the age of 65 years and 2.8% after the age of 75 years.

Moreover, the rising popularity of minimally invasive procedures such as transcatheter repair and replacement techniques in treating structural heart diseases, have further provided great landscape for the structural heart devices market growth.

However, the number of product recalls and rigid regulatory norms for product approval may restrain the growth of the structural heart devices market during the forecast period.

Structural Heart Devices Market Segment Analysis:

Structural Heart Devices market by Product Type (Repair Devices [Occluders, Annuloplasty Devices, Valvuloplasty Devices, Others] and Replacement Devices [Mechanical Heart Valves And Tissue Heart Valves]), Structural Heart Devices market by Application (Atrial Septal Defect, Aortic Valve Stenosis, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Regurgitation, And Others) Structural Heart Devices market by End User (Hospitals, Ambulatory Surgical Centers, And Others), and Structural Heart Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In product segment of the structural heart devices market, the repair devices category is expected to account for the larger market share compared to the replacement devices. This can be attributed to the preference of surgeons to repair procedures over replacement ones as the first choice. These is due to the several benefits associated with the repair procedures in treating structural heart defects such as repairing strategies tend to preserve the strength, and function of the heart muscle, reduces the chances of post-surgery infections such as endocarditis, offers better prognosis compared to replacement devices, and comparatively less dependency on blood-thinners.

In the repair category, annuloplasty devices are expected to amass significant market share due to their significant importance in valve repair, specifically the mitral valve. An annuloplasty ring is considered essential as it helps in restoring the shape and the size of the native annulus of the valve, it prevents future dilation of the annulus, and offers functional support to the annulus. Furthermore, these devices offer the flexibility to be administered as a treatment both via an open heart surgery or minimally invasive approach.

In October 2020, Genesee BioMedical Inc received the FDA approval for their TruForm Sievers Annuloplasty Ring, Model TRH for the treatment of the correction of mitral valvular insufficiency where the lesions are not so severe as to require total valve replacement.

However, the rising popularity of minimally invasive interventions such as transcatheter-based approaches for valve repair such as Edwards Cardioband Mitral Reconstruction System, MitraClip and Carillon Mitral Contour System are expected to witness a faster growth in demand in the forecast period.

North America is expected to dominate the Overall Strucutral Heart Devices Market:

Among all the regions, North America is expected to amass the largest share in the structural heart devices market. The growing prevalence of structural heart disease, better healthcare facilities coupled with the presence of major market players as well as supportive reimbursement programs in the region are predicted to be the major influencing factors in driving the overall growth of the structural heart devices market over the forecast period.

In North America, the US is expected to account for the largest share of the North American Structural Heart Devices market. This can be attributed to the increasing cases of structural heart diseases. According to the Centers for Disease Control and Prevention (CDC) data (2023), congenital heart diseases affect approximately 40,000 births per year in the country. It has been estimated that about one in 4 babies suffer from a critical form of CHD. The commonest type of heart defect is the ventricular septal defect.

As per the data provided by the CDC (2023), near about 2.5% of the US population suffers from valvular heart disease and it is more commonly observed in the older population.

Aortic stenosis is one of the commonest and serious valve disease problems and is one of the type of valvular heart diseases. The aortic valve opening becomes narrow in this indication which results in the restricted blood flow from the left ventricle to the aorta. As per the factsheet provided by the American Heart Association (2023), about 20% of the people in the United States over the age of 65 suffer from aortic stenosis.

Moreover, the large presence of key market players namely Abbott, Edwards Lifesciences Corporation, Livanova plc in the country as well as the launch of new products in the country also provide favorable conditions for the growth of the structural heart devices market.

In September 2020, the US Food and Drug Administration expanded the product approval for the The SAPIEN 3 and SAPIEN 3 Ultra THV System by Edwards Lifesciences Corporation to include the replacement of a failing (narrowed, leaky, or both) use previously implanted transcatheter aortic valve. The device has been previously approved to be used in the treatment of aortic stenosis as well as a replacement for the replacement of a failing (narrowed, leaky, or both) previously implanted surgical artificial aortic or mitral heart valve in patients who are too high risk for open-heart surgery. Such frequent revisions of the device applications and safety assessment by the country's regulatory authorities also play a key role in instilling faith in device manufacturers and end users.

Therefore, the market for structural heart devices in the United States and North America is predicted to witness significant growth in the forecast period.

Structural Heart Devices Market Key Players:

Some of the key market players operating in the structural heart devices market includes Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc, Abbott, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc, Biomerics, Lepu Medical Technology (Beijing) Co. Ltd, Livanova plc, Comed B.V., TORAY INDUSTRIES INC, Occlutech International AB, Microport Scientific Corporation and others.

Recent Developmental Activities in Structural Heart Devices Market:

In August 2022, Medtronic received the 510k clearance from the US Food and Drug Administration for their new-generation, self-expanding transcatheter aortic valve replacement (TAVR) system- Evolut FX TAVR system. This device is aimed at treating patients with symptomatic severe aortic stenosis while maintaining the feautres offered by their Evolut platform such as hemodynamics and durability.

In August 2022, Occlutech Holding AG was granted an Investigational Device Exemption (IDE) by the US FDA for their Flex II PFO Occluder. This IDE would allow the company to conduct a clinical study to gather safety and efficacy data for their device to support their premarket approval in order to access the US markets.

In March 2022, Medtronic received the 510k approval by the US FDA for their Harmony Transcatheter Pulmonary Valve System. This system is the first-ever non-surgical valve replacement device in the world for the treatment of certain types of congenital heart disease in both adult and pediatric populations.

Key Takeaways from the Structural Heart Devices Market Report Study

Market size analysis for current structural heart devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the structural heart devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global structural heart devices market.

Various opportunities available for the other competitor in the structural heart devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030?

Which is the top-performing regions and countries in the current structural heart devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for structural heart devices market growth in the coming future?

Target Audience who can be benefited from this Structural Heart Devices Market Report Study

Structural Heart Devices products providers

Research organizations and consulting companies

Structural Heart Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in structural heart devices

Various End-users who want to know more about the structural heart devices market and latest technological developments in the structural heart devices market.

Frequently Asked Questions for Structural Heart Devices Market:

1. What is are Structural Heart Devices?

Structural heart devices are various types of devices that are used in the treatment of structural heart defects. Depending upon the degree of the defect, different types of structural heart devices can be employed either in the repair of the defect or replacement, such as replacement of a heart valve.

2. What is the market for Global Structural Heart Devices?

Global Structural Heart Devices Market was valued at USD 8.82 billion in 2023, growing at a CAGR of 11.33% during the forecast period from 2024 to 2030 to reach USD 18.67 billion by 2030.

3. What are the drivers for Global Structural Heart Devices Market?

The major factors boosting the demand for Structural Heart Devices in the market the rising prevalence of structural heart diseases, increasing popularity of minimally invasive interventions, and favourable reimbursement programs related to these procedures.

4. What are the key players operating in Global Structural Heart Devices?

Some of the important market players operating in the the structural heart devices market includes Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc, Abbott, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc, Biomerics, Lepu Medical Technology (Beijing) Co. Ltd, Livanova plc, Comed B.V., TORAY INDUSTRIES INC, Occlutech International AB, Microport Scientific Corporation and others.

5. What region has the highest share in Structural Heart Devices market?

North America is projected to dominate the structural heart devices market in terms of revenue in the during the forecast period. This can be related to the high number of cases of structural heart diseases, better healthcare system, and presence of major market players in the region, primarily in the US.

Table of Contents

1.Structural Heart Devices Market Report Introduction

2.Structural Heart Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
    • 3.2.1. Germany
    • 3.2.2. France
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. U.K.
  • 3.3. Japan

4. Structural Heart Devices Market Key Factors Analysis

  • 4.1. Structural Heart Devices Market Drivers
    • 4.1.1. Rising Prevalence of Structural Heart Diseases
    • 4.1.2. Growing demand for Minimally-Invasive Procedures
    • 4.1.3. Technological Advancements Leading to New Product Development
    • 4.1.4. Inclusion of Structural Heart Devices In Various Reimbursement & Insurance Programs
  • 4.2. Structural Heart Devices Market Restraints and Challenges
    • 4.2.1. Frequent Product Failures and Recalls
    • 4.2.2. Stringent Product Approval Process
  • 4.3. Structural Heart Devices Market Opportunities
    • 4.3.1. Targeting Emerging Markets for Product Launches
    • 4.3.2. Product Improvement in Terms of Safety

5. Structural Heart Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Structural Heart Devices Market

7. Structural Heart Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. Repair Devices
      • 7.1.1.1. Occluders
      • 7.1.1.2. Annuloplasty Devices
      • 7.1.1.3. Valvuloplasty Devices
      • 7.1.1.4. Others
    • 7.1.2. Replacement Devices
      • 7.1.2.1. Mechanical Valves
      • 7.1.2.2. Tissue Valves
  • 7.2. By Application
    • 7.2.1. Atrial Septal Defects
    • 7.2.2. Aortic Valve Stenosis
    • 7.2.3. Patent Foramen Ovale
    • 7.2.4. Ventricular Septal Defects
    • 7.2.5. Mitral Valve Regurgitation
    • 7.2.6. Others
  • 7.3. By End User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Structural Heart Devices Market, by Product Type
      • 7.4.1.2. North America Structural Heart Devices Market, by Application
      • 7.4.1.2. North America Structural Heart Devices Market, by End User
      • 7.4.1.4. North America Structural Heart Devices Market, by Country
      • 7.4.1.1.1. United States
      • 7.4.1.1.2. Canada
      • 7.4.1.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Structural Heart Devices Market, by Product Type
      • 7.4.2.2. Europe Structural Heart Devices Market, by Application
      • 7.4.2.3. Europe Structural Heart Devices Market, by End User
      • 7.4.2.4. Europe Structural Heart Devices Market, by Country
      • 7.4.2.2.1. France
      • 7.4.2.2.2. Germany
      • 7.4.2.2.3. United Kingdom
      • 7.4.2.2.4. Italy
      • 7.4.2.2.5. Spain
      • 7.4.2.2.6. Russia
      • 7.4.2.2.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Structural Heart Devices Market, by Product Type
      • 7.4.3.2. Asia-Pacific Structural Heart Devices Market, by Application
      • 7.4.3.3. Asia-Pacific Structural Heart Devices Market, by End User
      • 7.4.3.4. Asia-Pacific Structural Heart Devices Market, by Country
      • 7.4.3.4.1. China
      • 7.4.3.4.2. Japan
      • 7.4.3.4.3. India
      • 7.4.3.4.4. Australia
      • 7.4.3.4.5. South Korea
      • 7.4.3.4.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. RoW Structural Heart Devices Market, by Product Type
      • 7.4.4.2. RoW Structural Heart Devices Market, by Application
      • 7.4.4.3. RoW Structural Heart Devices Market, by End User
      • 7.4.4.4. RoW Structural Heart Devices Market, by Country
      • 7.4.4.3.1. Middle East
      • 7.4.4.3.2. Africa
      • 7.4.4.3.3. South America

8. Structural Heart Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Structural Heart Devices Market Company and Product Profiles

  • 9.1. Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Boston Scientific Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Braile Biomedica
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Edwards Life Sciences Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Valcare Medical
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. W. L. Gore & Associates Inc
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Abbott
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. XELTIS BV
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. JenaValve Technology, Inc
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Lepu Medical Technology (Beijing) Co. Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Livanova plc
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Comed BV
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. TORAY INDUSTRIES INC
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Occlutech International AB
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Microport Scientific Corporation
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy

10. Project Approach

  • 10.1. Secondary Sources
  • 10.2. Primary Sources
  • 10.3. Data Triangulation
  • 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Structural Heart Devices Market
  • Table 3: Structural Heart Devices Market in Global (2021-2030)
  • Table 4: Structural Heart Devices Market in Global by Product Type (2021-2030)
  • Table 5: Structural Heart Devices Market in Global by Application (2021-2030)
  • Table 6: Structural Heart Devices Market in Global by End User (2021-2030)
  • Table 7: Structural Heart Devices Market in Global by Geography (2021-2030)
  • Table 8: Structural Heart Devices Market in North America (2021-2030)
  • Table 9: Structural Heart Devices Market in North America by Product Type (2021-2030)
  • Table 10: Structural Heart Devices Market in North America by Application (2021-2030)
  • Table 11: Structural Heart Devices Market in North America by End User (2021-2030)
  • Table 12: Structural Heart Devices Market in North America by Country (2021-2030)
  • Table 13: Structural Heart Devices Market in the US (2021-2030)
  • Table 14: Structural Heart Devices Market in Canada (2021-2030)
  • Table 15: Structural Heart Devices Market in Mexico (2021-2030)
  • Table 16: Structural Heart Devices Market in Europe (2021-2030)
  • Table 17: Structural Heart Devices Market in Europe by Product Type (2021-2030)
  • Table 18: Structural Heart Devices Market in Europe by Application (2021-2030)
  • Table 19: Structural Heart Devices Market in Europe by End User (2021-2030)
  • Table 20: Structural Heart Devices Market in Europe by Country (2021-2030)
  • Table 21: Structural Heart Devices Market in France (2021-2030)
  • Table 22: Structural Heart Devices Market in Germany (2021-2030)
  • Table 23: Structural Heart Devices Market in the United Kingdom (2021-2030)
  • Table 24: Structural Heart Devices Market in Italy (2021-2030)
  • Table 25: Structural Heart Devices Market in Spain (2021-2030)
  • Table 26: Structural Heart Devices Market in Russia (2021-2030)
  • Table 27: Structural Heart Devices Market in Rest of Europe (2021-2030)
  • Table 28: Structural Heart Devices Market in APAC (2021-2030)
  • Table 29: Structural Heart Devices Market in APAC by Product Type (2021-2030)
  • Table 30: Structural Heart Devices Market in APAC by Application (2021-2030)
  • Table 31: Structural Heart Devices Market in APAC by End User (2021-2030)
  • Table 32: Structural Heart Devices Market in APAC by Country (2021-2030)
  • Table 33: Structural Heart Devices Market in China (2021-2030)
  • Table 34: Structural Heart Devices Market in Japan (2021-2030)
  • Table 35: Structural Heart Devices Market in India (2021-2030)
  • Table 36: Structural Heart Devices Market in Australia (2021-2030)
  • Table 37: Structural Heart Devices Market in South Korea (2021-2030)
  • Table 38: Structural Heart Devices Market in Rest of APAC (2021-2030)
  • Table 39: Structural Heart Devices Market in Rest of World (2021-2030)
  • Table 40: Structural Heart Devices Market in RoW by Product Type (2021-2030)
  • Table 41: Structural Heart Devices Market in RoW by Application (2021-2030)
  • Table 42: Structural Heart Devices Market in RoW by End User (2021-2030)
  • Table 43: Structural Heart Devices Market in RoW by Region (2021-2030)
  • Table 44: Structural Heart Devices Market in Middle East (2021-2030)
  • Table 45: Structural Heart Devices Market in Africa (2021-2030)
  • Table 46: Structural Heart Devices Market in South America (2021-2030)

List of Figures

Figures 1: Competitive Analysis

Figures 2: COVID-19 Impact Analysis on Structural Heart Devices Market

Figures 3: Structural Heart Devices Market in Global (2021-2030)

Figures 4: Structural Heart Devices Market in Global by Product Type (2021-2030)

Figures 5: Structural Heart Devices Market in Global by Application (2021-2030)

Figures 6: Structural Heart Devices Market in Global by End User (2021-2030)

Figures 7: Structural Heart Devices Market in Global by Geography (2021-2030)

Figures 8: Structural Heart Devices Market in North America (2021-2030)

Figures 9: Structural Heart Devices Market in North America by Product Type (2021-2030)

Figures 10: Structural Heart Devices Market in North America by Application (2021-2030)

Figures 11: Structural Heart Devices Market in North America by End User (2021-2030)

Figures 12: Structural Heart Devices Market in North America by Country (2021-2030)

Figures 13: Structural Heart Devices Market in the US (2021-2030)

Figures 14: Structural Heart Devices Market in Canada (2021-2030)

Figures 15: Structural Heart Devices Market in Mexico (2021-2030)

Figures 16: Structural Heart Devices Market in Europe (2021-2030)

Figures 17: Structural Heart Devices Market in Europe by Product Type (2021-2030)

Figures 18: Structural Heart Devices Market in Europe by Application (2021-2030)

Figures 19: Structural Heart Devices Market in Europe by End User (2021-2030)

Figures 20: Structural Heart Devices Market in Europe by Country (2021-2030)

Figures 21: Structural Heart Devices Market in France (2021-2030)

Figures 22: Structural Heart Devices Market in Germany (2021-2030)

Figures 23: Structural Heart Devices Market in the United Kingdom (2021-2030)

Figures 24: Structural Heart Devices Market in Italy (2021-2030)

Figures 25: Structural Heart Devices Market in Spain (2021-2030)

Figures 26: Structural Heart Devices Market in Russia (2021-2030)

Figures 27: Structural Heart Devices Market in Rest of Europe (2021-2030)

Figures 28: Structural Heart Devices Market in APAC (2021-2030)

Figures 29: Structural Heart Devices Market in APAC by Product Type (2021-2030)

Figures 30: Structural Heart Devices Market in APAC by Application (2021-2030)

Figures 31: Structural Heart Devices Market in APAC by End User (2021-2030)

Figures 32: Structural Heart Devices Market in APAC by Country (2021-2030)

Figures 33: Structural Heart Devices Market in China (2021-2030)

Figures 34: Structural Heart Devices Market in Japan (2021-2030)

Figures 35: Structural Heart Devices Market in India (2021-2030)

Figures 36: Structural Heart Devices Market in Australia (2021-2030)

Figures 37: Structural Heart Devices Market in South Korea (2021-2030)

Figures 38: Structural Heart Devices Market in Rest of APAC (2021-2030)

Figures 39: Structural Heart Devices Market in Rest of World (2021-2030)

Figures 40: Structural Heart Devices Market in RoW by Product Type (2021-2030)

Figures 41: Structural Heart Devices Market in RoW by Application (2021-2030)

Figures 42: Structural Heart Devices Market in RoW by End User (2021-2030)

Figures 43: Structural Heart Devices Market in RoW by Region (2021-2030)

Figures 44: Structural Heart Devices Market in Middle East (2021-2030)

Figures 45: Structural Heart Devices Market in Africa (2021-2030)

Figures 46: Structural Heart Devices Market in South America (2021-2030)

Figures 47: Market Drivers

Figures 48: Market Barriers

Figures 49: Marker Opportunities

Figures 50: PORTER'S Five Force Analysis